Dorel-Ionel Popovici

10PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHistory and philosophy of medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 13, 2026
Artificial Intelligence-Guided Personalized Gut Microbiome Modulation for Persistent Secondary Gastrointestinal Symptoms in Oncology Patients: Clinical Efficacy and Biological Correlates from a Prospective Validation Study.

|Nov 27, 2025
Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.

Mohammed Saad AlQahtani, Bogdan Miutescu, Ielmina Domilescu

|Aug 14, 2025
Decoding Treatment Failures in Metastatic Renal Cell Carcinoma: Predictors Across Immunotherapy and Targeted Therapies from a Retrospective Real-World Analysis.

Sorin Saftescu, Vlad-Norin Vornicu, Dorel-Ionel Popovici

|Mar 27, 2025
The Role of Initial Neutropenia and Neutrophil Dynamics in Personalizing Chemotherapy for Platinum-Resistant Ovarian Cancer.

Radu-Dumitru Dragomir, Alina-Gabriela Negru, Marina-Adriana Mercioni

|Feb 26, 2025
Association Between Advanced TNM Stages and Increased Risk of Cardiac Dysfunction in Patients with LVEF < 50.

Sergiu Ioan Murg, Loredana Matiș, Andrada Florina Moldovan

|Jan 24, 2025
Comparison of Hepatic Function and Chemotherapy-Induced Side Effects Between Pegylated Liposomal Doxorubicin (PLD), Topotecan (TOPO), and Gemcitabine in Platinum-Resistant Ovarian Cancer (PROC).

Radu-Dumitru Dragomir, Marina Adriana Mercioni, Șerban Negru

Pageof 2

Frequent Collaborators

5 joint publications

Radu-Dumitru Dragomir

4 joint publications

Sorin Saftescu

3 joint publications

Alina-Gabriela Negru

2 joint publications

Alexandru Catalin Motofelea